Abstract Pathogenic microbes have mutated and developed resistance to the latest range of antibiotics, which has kept synthetic chemist hunting for better and least toxic antimicrobial agents. Cyclocondensation of substituted anilines with 3-phenyl-2-propenoic acid yielded Phenyl-(substitu ted)-quinolin-2-one derivatives (1a-1t). In the next step phenylquinolin-2-one acetic acid derivatives (2a-2t) were prepared by the treatment of (1a-1t) with chloroacetic acid. Further (2a-2t) derivatives were reacted with thiocarbohydrazide to obtain a series of 4-amino-5-sulfanyl-4,5-dihydro-1,2,4-tria zolo-4-pheny-(substituted)-quinolin-2-one derivatives (3a-3t). Then condensation of (3a-3t) with phenacyl bromide provided series of fused heterocyclic derivatives of 4-phenyl-1-({6-phenyl-7H-[1 ,2,4]triazolo [3,4-b][1,3,4]thiadiazin-3-yl}methyl)-(substituted)-1,2-dihydro quinolin-2-one (4a-4t). Structures of these newly synthesized derivatives were established by elemental analysis, FT-IR, 1 H NMR and Mass spectroscopy. Final derivatives (4a-4t) were screened for their in vitro antibacterial and antifungal activities against the standard drugs Ampicillin and Fluconazole respectively. The compounds 4d, 4g and 4j showed potent activity against all the studied microbes. Particularly compounds substituted with halogen groups at para position of phenylquinoline ring exhibited significant antimicrobial activity against studied microbes. 
Introduction
Rapid increase in pathogenic fungi and bacteria that are multi resistant to antibiotics has become major threat in treatment of infectious diseases. Heterocyclic compounds having 1,2,4-triazolo ring system substituted with nitrogen and sulfur exhibit a wide range of biological activities such as antibacterial (Guzeldemirci and Kucukbasmac, 2010; Karegoudar et al., 2008) , antifungal (Fang et al., 2010; Banday and Rauf, 2009) , antitubercular (Bhat et al., 2004) properties. Also a number of Quinoline derivatives have been well known to possess a variety of pharmacological activities like antibacterial (Zitouni et al., 2005) , antifungal (Purohit et al., 2011) and anti-inflammatory (Tozkoparan et al., 2000; Amir et al., 2008; Chen et al., 2006; Abdel-Megeed et al., 2009) . Literature survey reveals that heterocyclic compounds containing halogen atoms have attracted attention due to ability of halogens to act as hydroxy mimic agent. So substitution of hydrogen by halogens and other substituents plays an important role in designing new pharmacophores for biological studies. Various compounds containing 1,2,4-Triazolo nucleus are well known as powerful antibacterial (Varvaresou et al., 2000) , antifungal and antimycobacterial agents (Sridharaa et al., 2010; Karegoudar et al., 2008) . Moreover the use of heterocyclic compounds containing 1,3,4-Thiadiazoles and 1,3,4-Thiadiazines is widely known due to their therapeutic effects against pathological conditions such as pain, inflammation, and hypertension (Ahmad et al., 2012; Clerici et al., 2001) . The synthesis of heterocyclic rings containing both 1, 2, 4-Triazolo nucleus and 1, 3, 4-Thiadiazine ring has attracted attention due to their antimicrobial (Goksen et al., 2007) , analgesic (Turan-Zitouni et al., 1999) , antiviral and anti-inflammatory properties (Isloor et al., 2009; Abadi et al., 2005) . The problem of drug resistance of the pathogenic strains of microbes to the older derivatives of triazoles is a well-known fact for the researchers. Therefore it was planned to synthesize a new series of 4-phenyl-1-({6-phenyl-7H-[1,2,4]tria zolo [3,4-b] [1, 3, 4] thiadiazin-3-yl}methyl)-(substituted)-1,2-dihy droquinolin-2-one (4a-4t) derivatives by linking (substituted)-4-phenylquinolin-2(1H)-one with 1,2,4-triazolo [3,4-b] [1,3,4]thi adiazine moiety ( Fig. 1 ) and to evaluate their in vitro antimicrobial activity.
Materials and methods

General
The entire chemicals required for the synthesis and other experimental work were purchased from Merck, Sigma Aldrich and Rankem chemical company. Melting points of all synthesized compounds were determined in open capillaries by Temp Star apparatus and are uncorrected. The purity of the compounds was routinely checked in each step by TLC using Silica Gel 60G and the developed plates were visualized by UV light. Spectroscopic data were recorded by the following instruments; IR spectra were recorded on FT-IR-8400S, Schimadzu, Japan, 1 H NMR spectra were recorded by Bruker DRX -300 MHz FT NMR with low and high temperature facility (À90°C to +80°C) in the solvents CDCl 3 . Chemical shifts are reported in parts per million (d) and signals are described as singlet (s), doublet (d), triplet (t), quartet (q) and multiplet (m). The Mass spectra were obtained by Agilent 6520 Q-TOF (ESI-MS) and Elemental analysis was done by Elemental Analyzer: Vario EL-III.
Chemistry
In the present work twenty novel derivatives of phenylquino line-1,2,4-triazolothiadiazines were synthesized, following the synthetic route given in Scheme 1. The starting material phenylquinoline-2-one derivatives (1a-1t) for the synthesis of desired compounds were obtained by cyclocondensation (Lipson et al., 2000) of Aniline derivatives with 3-phenyl-2-propenoic acid (Cinnamic acid) in the presence of ethanol, conc. H 2 SO 4 and Nitrobenzene. In this step conc. H 2 SO 4 acts as condensing reagent and catalyst to favor forward reaction. Then the compounds (1a-1t) on the treatment with chloroacetic acid in the presence of alkaline medium provided 2-oxophe nyl-(substituted)-quinolin-1-ylacetic acid derivatives (2a-2t). In the next step (2a-2t) on heating with thiocarbohydrazide gave 4-amino-5-sulfanyl-4,5-dihydro-1,2,4-triazol-4-phenyl-(substituted)-quinolin-2-one (3a-3t) in good yield. Then cyclization of (3a-3t) with phenacyl bromide in the presence of anhydrous ethanol provided the desired product 4-phenyl-1-({6-phenyl-7H-[1,2,4]triazolo [3,4-b] [1,3,4]thiadiazol-3-yl}methyl)-(substituted)-1,2-dihydroquino line-2-one (4a-4t). The synthesized compounds were purified and recrystallized using ethanol and acetone. The characterization of these new derivatives was done by their Elemental analysis and spectroscopic (FT-IR, 1 H NMR and MASS) data.
Figure 1 General structure of final synthesized derivatives.
General procedure for the synthesis of Phenyl-(substituted)-quinolin-2-one derivatives (1a-1t)
Equimolar quantity of aniline derivatives (0.1 mol) and 3-phenyl-2-propenoic acid (14.8 g, 0.1 mol) were refluxed for 4 h using 20 ml of ethanol in the presence of 2-4 drops of conc. Sulfuric acid and 2-3 drops of nitrobenzene. After refluxing the resulting product was kept at room temperature and then filtered. The filtered product was left for overnight to dry in hot air oven by maintaining temperature 40°C and then the product was recrystallized from ethanol.
2.4. General procedure for the synthesis of 2-oxo-4-phenyl-(substituted)-quinolin-acetic acid derivatives (2a-2t)
In this step the compounds (1a-1t) 0.01 mol refluxed with Chloroacetic acid (0.94 g, 0.01 mol) in the presence of NaHCO 3 , CuO and water for 2 h. The resulting solution was filtered and allowed to cool at room temperature. To the filtrate dilute HCl was added. The solid thus separated out was dried and recrystallized from ethanol.
2.5. General procedure for the synthesis of 4-amino-5-sulfanyl-4,5-dihydro-1,2,4-triazolo-4-phenyl-(substituted)-quinolin-2-one (3a-3t)
Mixture of 2a-2t (0.03 mol) and thiocarbohydrazide (3.18 g, 0.03 mol) was heated till all the contents melted. A homogenous reaction mixture was obtained during reaction process. Then the product was treated with dilute sodium carbonate solution. The white solid separated out was filtered, washed twice with cold water. Then the product was recrystallized from Acetone.
General procedure for the synthesis of
The synthesized compounds 3a-3t (0.003 mol) were refluxed with Phenacylbromide (0.597 g, 0.003 mol) in the presence of anhydrous ethanol (30 ml) with continuous stirring for 6 h. The resulting reaction mixture was allowed to attain room temperature and was neutralized with 20% NH 4 OH solution.
The separated precipitate was the filtered and recrystallized from ethanol to obtain the final derivatives (4a-4t). Minimal Inhibitory Concentrations (MICs, lg/mL) were determined on different microbes using Broth Micro Dilution procedure according to the recommendations of National Committees for Clinical Laboratory Standards (NCCLS) (Barry, 1991; CLSI Document, 2006; NCCLS Document, 2002) . MIC was defined as the lowest conc. of compound that inhibited visible growth of microbes after incubation at 35°C for 24 h. for bacteria and 48 h for fungi. Strains of gram Àve bacteria Pseudomonas aeruginosa (MCCB 0035), Escherichia coli (ATCC 8739) and gram +ve bacteria Staphylococcus aureus (ATCC 29213) and fungal strains Aspergillus fumigatus (NCIM 2081), Aspergillus niger (NCIM 2191), Candida albicans (NCIM 2087) were used for testing antibacterial and antifungal activities. Bacterial strains were grown in Mueller-Hinton Broth and fungal strains were grown in Sabouraud Liquid medium. The inoculum densities of 5 · 10 5 CFU/mL for bacteria and 0.5-2.5 · 10 3 CFU/mL for fungi were prepared. Ampicillin Anhydride and fluconazole were used as standard antibiotic powder. The synthesized compounds were dissolved in DMSO and further dilutions were prepared in sterile distilled water of various concentrations by twofold serial dilution method to obtain the required concentration 512, 256, 128, 64, 32, 16, 8, 4 , 2, 1, 0.5, 0.25 lg/mL. Ampicillin anhydride and fluconazole were diluted in sterile distilled water. Twofold dilutions of the compound and standards were prepared as 512-0.5 lg/mL and 64-0.25 lg/mL concentrations respectively. After dilution was completed, microbe suspensions were inoculated into each well of row. MIC values were given as lg/mL. The turbidity was monitored visually and spectrophotometrically and the lowest concentration, at which no growth was seen, recorded and considered as MIC of that particular compound. The MIC of the synthesized compounds and standard drug has been summarized in Table 2 .
Agar Disk Diffusion
Agar Disk Diffusion testing technique was used as per CLSI guidelines for evaluating antimicrobial potentials of synthesized derivatives with suitable modification. Mueller-Hinton Agar (MHA) petri plates was prepared, standardized and then inoculated with standardized test organism suspension. Stock solution of synthesized compounds was prepared in DMSO and further diluted with distilled water to get concentration of test compounds 100 lg/ml, ampicillin (100 lg/ml) and Clotrimazole (100 lg/ml). Disk of 8 mm diameter was prepared from Whatman filter paper and sterilized by keeping in hot air oven at 140°C for 1 h. Further the standard and test solution were added to each disk (100 lg/8 mm disk) and then with the help of sterile forceps placed on agar plates one at a time. In a plate three disks were applied by triplicate manner and it was ensured that disk made complete contact with agar layer. Bottom of the agar plates was labeled and incubated at temperature 35°C for 24 h and 48 h for bacterial and fungal strains in BOD incubator. Measurement of zone of inhibition produced by test compounds and standard drug against microbial growth was done using a scale. Final data of zone of inhibition obtained by different test compounds as compared with that of standard have been enumerated in (Table 3) .
Results and discussion
Chemistry
In the present work twenty derivatives of phenylquinoline-1, 2,4-triazolothiadiazines were synthesized. The structures of the synthesized compounds were established by spectral data. According to IR spectroscopic data compounds (4a-4t) showed peaks at 1306-1330 cm À1 , 650-682 cm À1 due to -N‚C and CASAC stretching vibrations respectively and no absorption peaks at 3140-3280 cm À1 , 3050-3090 cm À1 due to -NH 2 and -SH groups respectively indicated smooth cyclization of triazoles leading to the formation of thiadiazine ring. Further, 1 H NMR spectra of the synthesized compounds were confirmed by the appearance of SACH 2 proton of 1,3,4-thiadiazine ring at 4.40-4.54 ppm and ACH 2 proton at 5.97-6.20 ppm as broad singlet. All other aromatic protons were observed at expected region. Mass spectra (ESI-MS) of all the synthesized compounds showed molecular ion [M + H] + peak in agreement with their molecular formula. Physical and elemental analyses are listed in Table 1. 3.2. In-vitro antimicrobial assay/studies 3.2.1. Antibacterial activity All the synthesized derivatives (4a-4t) were tested for their in vitro antimicrobial activity against gram positive (S. aureus) and gram negative (E. coli, P. aeruginosa) bacteria and results have been presented in Tables 2 and 3 . The resultant MIC value of synthesized compounds was found in good agreement with the results of zone of inhibition. Compounds 4d, 4g and 4j having substitution at sixth position of phenyl quinolone ring showed highest activity against all studied bacterial strains. Highest activity was shown by compound 4d at MIC value 1 lg/mL against S. aureus, 2 lg/mL against E. Coli and 4 lg/mL P. aeruginosa. Other derivatives 4c, 4f, and 4i showed comparable activity as compared with standard drug as these had substitution by halogen atoms at seventh position of core pharmacophore phenylquinoline ring. Compounds 4b, 4e, 4h, 4m and 4r also possessed some activity against tested bacterial strains. Further replacement of halogen groups with methyl, nitro, methoxy and tri-methoxy groups reduced antibacterial potentials and compounds 4a, 4k, 4l, 4n, 4o, 4p, 4q, 4s and 4t showed least activity as revealed from MIC study from Table 2 .
Antifungal activity
Compounds 4d, 4g and 4j showed highest activity against tested fungal strains in comparison with clotrimazole. Both MIC and Zone of Inhibition data from Tables 2 and 3 reveal that halogen substitution at sixth position of phenylquinoline ring. Compounds 4d and 4j showed nearly equipotent activity as compared with standard drug at MIC concentration of 2 lg/mL and 4 lg/mL against A. niger and C. albicans whereas compound 4g was the most potent at 1 lg/mL concentration against C. albicans. Compounds 4b, 4c, 4e, 4f, 4h and 4i showed moderate activity as hydrogen was substituted with bromo, chloro and fluro atoms at seventh and eighth position of phenylquinoline ring. Antifungal activity further decreased in compounds 4k, 4l, 4m, 4o, 4p, 4q, 4r and 4s having methyl, nitro and methoxy groups at various position of phenylquinoline ring. Least activity was seen in 4a and 4n against all studied fungal strains.
Structure activity relationship of antimicrobial study
MIC and Zone of Inhibition data showed and clarified Structure-activity relationship analysis of final synthesized derivatives. The study suggested that compounds having substitution on sixth, seventh and eight position of lg/mL of 1,2,4-triazolo thiadiazines (4a-4t) a,b against Bacterial and Fungal phenylaquinoline ring by halogen atom possessed good activity. Specially having substitution at sixth position by halogen group, compounds 4d, 4g and 4j emerged to be most useful as they were having highest activity against both studied fungal and bacterial strains, whereas substitution by electron donating groups, like compounds 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r, 4s and 4t having methyl, nitro, methoxy and trimethoxy groups was not as effective as halogen substituents.
Conclusion
In this study we have successfully synthesized and reported synthesis of novel 1,2,4-triazolo [3,4-b] [1,3,4]thiadiazine bearing substituted phenylquinolin-2-one hybrids. This study showed some 1,2,4-triazolo thiadiazines derivatives bearing phenyl quinoline moiety possessed moderate to good antibacterial and antifungal activities. The antimicrobial study suggested that compounds (4a-4t) by halogen substitution on sixth position of phenylquinoline ring (4d, 4g and 4j) showed highest activity against all studied microbial strains. Other compounds also possessed some activity but failed to attract more attention in comparison with standard drugs. The authors are working further to optimize compounds with good activity and findings will be reported in further publications.
